Sol-Gel Technologies and Beimei Pharma Collaborate to Commercialize Twyneo for Treating Acne Vulgaris
Shots: Sol-Gel Technologies has entered into an asset purchase agreement with Shen...
AbbVie Partners with Gilgamesh Pharmaceuticals to Develop Next-Generation Therapies for Psychiatric Disorders
Shots: AbbVie & Gilgamesh have teamed up & signed an option-to-license agr...
Takeda and AC Immune Collaborate for ACI-24.060 to Treat Alzheimer’s Disease
Shots: Takeda & AC Immune have entered into an exclusive, worldwide option &am...
Fulcrum Therapeutics Partners with Sanofi to Develop and Commercialize Losmapimod for Facioscapulohumeral Muscular Dystrophy
Shots: Fulcrum & Sanofi have signed a collaboration & license agreement to...
Shionogi Partners with Maze Therapeutics for MZE001’s Rights to Treat Pompe Disease
Shots: Following the completion of transaction and expiry of 30-day waiting period...
Flagship Pioneering and Metaphore Biotechnologies Partner with Novo Nordisk to Develop Therapies for Obesity
Shots: Metaphore & Flagship Pioneering have teamed up with Novo Nordisk to dev...
